Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613)

Beijing Tong Ren Tang Chinese Medicine Company Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,721	999.81	1,991	1,660	1,426	1,057
Short-Term Investments	71.65	1,398	271.33	633.02	440.37	930.65
Cash & Short-Term Investments	1,793	2,398	2,262	2,293	1,866	1,987
Cash Growth	-27.44%	6.00%	-1.35%	22.87%	-6.09%	-13.13%
Accounts Receivable	285.54	395.24	923.23	526.48	546.45	313.04
Other Receivables	17.39	27.74	18.77	16.06	0.97	1.11
Receivables	302.93	422.99	942	542.54	547.42	314.16
Inventory	1,602	1,012	469.78	431.87	495.38	318.19
Prepaid Expenses	11.52	11.62	8.99	9.09	23.74	24.11
Total Current Assets	3,713	3,844	3,683	3,277	2,933	2,644
Property, Plant & Equipment	421.61	425.63	393.35	397.56	381.82	389.93
Long-Term Investments	53.08	59.8	62.61	63.36	23.87	29.53
Goodwill	49.42	49.42	49.42	49.42	49.42	49.42
Other Intangible Assets	5.28	6.97	10.29	11.53	5.42	11.25
Long-Term Deferred Tax Assets	20.12	37.12	14.81	22.05	13.06	8.94
Other Long-Term Assets	15.77	11.19	11.72	14.25	10.43	5.45
Total Assets	4,278	4,434	4,225	3,835	3,417	3,138
Accounts Payable	78.12	176.98	153.71	34.6	74.13	65.91
Accrued Expenses	58.72	65.22	77.03	88.45	62.27	74.76
Current Portion of Long-Term Debt	0.17	0.17	0.22	0.48	0.26	0.22
Current Portion of Leases	55.82	56.25	42.13	52.72	40.6	39.43
Current Income Taxes Payable	24.62	28.09	140.81	32.31	35.62	124.6
Current Unearned Revenue	3.62	3.21	4.68	4.51	3.73	2.16
Total Current Liabilities	221.07	329.92	418.57	213.06	216.62	307.08
Long-Term Debt	0.08	0.17	0.33	0.8	2.05	0.83
Long-Term Leases	77.89	75.23	60.4	74.48	63.1	59.4
Long-Term Deferred Tax Liabilities	9.22	8.44	7.18	7.15	5.7	5.38
Total Liabilities	308.26	413.76	486.49	295.48	287.46	372.69
Common Stock	938.79	938.79	938.79	938.79	938.79	938.79
Retained Earnings	2,921	2,977	2,713	2,511	2,104	1,754
Comprensive Income & Other	-53.56	-49.42	-47.3	-31.4	-25.15	-33.21
Total Common Equity	3,806	3,867	3,604	3,418	3,017	2,660
Minority Interest	163.64	154.18	134.31	121.33	112.02	106.14
Shareholders' Equity	3,970	4,021	3,739	3,540	3,130	2,766
Total Liabilities & Equity	4,278	4,434	4,225	3,835	3,417	3,138
Total Debt	133.97	131.81	103.08	128.48	106.01	99.88
Net Cash (Debt)	1,659	2,266	2,159	2,165	1,760	1,887
Net Cash Growth	-29.18%	4.96%	-0.26%	22.97%	-6.73%	-17.45%
Net Cash Per Share	1.98	2.71	2.58	2.59	2.10	2.25
Filing Date Shares Outstanding	837.1	837.1	837.1	837.1	837.1	837.1
Total Common Shares Outstanding	837.1	837.1	837.1	837.1	837.1	837.1
Working Capital	3,491	3,514	3,264	3,064	2,716	2,337
Book Value Per Share	4.55	4.62	4.31	4.08	3.60	3.18
Tangible Book Value	3,751	3,810	3,545	3,357	2,963	2,599
Tangible Book Value Per Share	4.48	4.55	4.23	4.01	3.54	3.10
Land	-	61.48	61.36	48.82	48.82	48.15
Buildings	-	147.45	146.71	134.46	134.21	131.91
Machinery	-	119.28	108.43	109.86	105.92	102.37
Leasehold Improvements	-	80.55	72.25	68.21	67.75	69.63

Source: S&P Capital IQ. Standard template. Financial Sources.